Article Information
History
- September 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rahul Ukey, PhD1,*,
- Natalie Bruiners, PhD1,2,*,
- Hridesh Mishra, PhD1,*,
- Pankaj K. Mishra, PhD1,*,
- Deborah McCloskey, RN3,
- Alberta Onyuka, MS4,
- Fei Chen, RN3,
- Abraham Pinter, PhD1,2,
- Daniela Weiskopf, PhD5,
- Alessandro Sette, PhD5,6,
- Jason Roy, PhD7,
- Sunanda Gaur, MD8 and
- Maria Laura Gennaro, MD1,2,**
- 1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ
- 2Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ
- 4Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ
- 3Clinical Research Center, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
- 5Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA
- 6Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA
- 7Department of Biostatistics and Epidemiology, School of Public Health, Rutgers University, Piscataway, NJ
- 8Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
- ↵**Corresponding author: ICPH building, W250Q, 225 Warren Street, Newark, NJ, 07103, USA., Phone +1-873-854-3210. Email marila.gennaro{at}rutgers.edu
↵* Equal contribution
Posted September 21, 2021.
Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
